Cas:124899-75-8 allyl amyl glycolate manufacturer & supplier

Chemical Name:allyl amyl glycolate

CAS.NO:124899-75-8

Synonyms:glycolic acid,2-pentyloxy:allyl ester

Molecular Formula:C₁₀H₁₈O₃

Molecular Weight:186.24800

HS Code:

Physical and Chemical Properties:

Melting point:270-273ºC

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:35.53000

Exact Mass:186.12600

LogP:1.92240

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like glycolic acid,2-pentyloxy:allyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,glycolic acid,2-pentyloxy:allyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,glycolic acid,2-pentyloxy:allyl ester Use and application,glycolic acid,2-pentyloxy:allyl ester technical grade,usp/ep/jp grade.

Related News: In approving the first new Alzheimer’s drug in nearly 20 years, the U.S. Food and Drug Administration is taking its biggest risk yet with a strategy that allows new therapies onto the market without strong evidence that they work, regulatory and scientific experts say. allyl amyl glycolate manufacturer A week after the memo was released to employees, Reuters reported that the Justice Department had launched a criminal investigation focused on the Branchburg plant. That same day, May 27, Lilly reported to the U.S. Securities and Exchange Commission that it had received a subpoena from the department seeking documents related to the factory. allyl amyl glycolate supplier We manufacture APIs and drug manufacturers make medicines from APIs. allyl amyl glycolate vendor The researchers found that compared with those with cancer, the prevalence of FT was higher among those with ASCVD (54 versus 41 percent). In adjusted analyses, when studying individual components of FT, those with ASCVD had increased odds of any difficulty paying medical bills, inability to pay bills, cost-related medication nonadherence, food insecurity, and foregone/delayed care due to cost (odds ratios, 1.22, 1.25, 1.28, 1.39, and 1.17, respectively). allyl amyl glycolate factory The researchers found that compared with those with cancer, the prevalence of FT was higher among those with ASCVD (54 versus 41 percent). In adjusted analyses, when studying individual components of FT, those with ASCVD had increased odds of any difficulty paying medical bills, inability to pay bills, cost-related medication nonadherence, food insecurity, and foregone/delayed care due to cost (odds ratios, 1.22, 1.25, 1.28, 1.39, and 1.17, respectively).